XML 15 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at Dec. 31, 2022 $ 2,451,294 $ 19,470 $ 1,755,963 $ (49,868) $ 725,729
Balance, Shares at Dec. 31, 2022   155,759,000      
Net issuance of common stock under stock-based plans (3,703) $ 79 (3,782)    
Net issuance of common stock under stock-based plans (in shares)   631,000      
Stock-based compensation expense 32,409   32,409    
Repurchase of common stock (233,884) $ (280)     (233,604)
Repurchase of common stock (in shares)   (2,242,000)      
Cash dividends (34,210)       (34,210)
Settlements of convertible notes   $ 47 (47)    
Settlements of convertible notes (in shares)   375,000      
Exercise of convertible notes hedge call options   $ (47) 47    
Exercise of convertible notes hedge call options (in shares)   (375,000)      
Net income 203,581       203,581
Other comprehensive income (loss) 19,396     19,396  
Balance at Jul. 02, 2023 2,434,883 $ 19,269 1,784,590 (30,472) 661,496
Balance, Shares at Jul. 02, 2023   154,148,000      
Balance at Apr. 02, 2023 2,449,462 $ 19,431 1,772,352 (36,466) 694,145
Balance, Shares at Apr. 02, 2023   155,445,000      
Net issuance of common stock under stock-based plans 168 $ 7 161    
Net issuance of common stock under stock-based plans (in shares)   52,000      
Stock-based compensation expense 12,077   12,077    
Repurchase of common stock (135,837) $ (169)     (135,668)
Repurchase of common stock (in shares)   (1,349,000)      
Cash dividends (17,031)       (17,031)
Settlements of convertible notes 0 $ 6 (6)    
Settlements of convertible notes (in shares)   50,000      
Exercise of convertible notes hedge call options 0 $ (6) 6    
Exercise of convertible notes hedge call options (in shares)   (50,000)      
Net income 120,050       120,050
Other comprehensive income (loss) 5,994     5,994  
Balance at Jul. 02, 2023 2,434,883 $ 19,269 1,784,590 (30,472) 661,496
Balance, Shares at Jul. 02, 2023   154,148,000      
Balance at Dec. 31, 2023 2,525,897 $ 19,087 1,827,274 (26,978) 706,514
Balance, Shares at Dec. 31, 2023   152,698,000      
Net issuance of common stock under stock-based plans 8,446 $ 73 8,373    
Net issuance of common stock under stock-based plans (in shares)   591,000      
Stock-based compensation expense 30,818   30,818    
Warrant exercises (12) $ 1,102 (1,114)    
Warrant exercises (in shares)   8,812,000      
Repurchase of common stock (30,290) $ (37)     (30,253)
Repurchase of common stock (in shares)   (299,000)      
Cash dividends (37,391)       (37,391)
Net income 250,470       250,470
Other comprehensive income (loss) (17,126)     (17,126)  
Balance at Jun. 30, 2024 2,730,812 $ 20,225 1,865,351 (44,104) 889,340
Balance, Shares at Jun. 30, 2024   161,802,000      
Balance at Mar. 31, 2024 2,557,829 $ 19,220 1,848,088 (39,739) 730,260
Balance, Shares at Mar. 31, 2024   153,757,000      
Net issuance of common stock under stock-based plans 4,630 $ 15 4,615    
Net issuance of common stock under stock-based plans (in shares)   125,000      
Stock-based compensation expense 13,660   13,660    
Warrant exercises (12) $ 1,000 (1,012)    
Warrant exercises (in shares)   7,998,000      
Repurchase of common stock (8,195) $ (10)     (8,185)
Repurchase of common stock (in shares)   (78,000)      
Cash dividends (19,008)       (19,008)
Net income 186,273       186,273
Other comprehensive income (loss) (4,365)     (4,365)  
Balance at Jun. 30, 2024 $ 2,730,812 $ 20,225 $ 1,865,351 $ (44,104) $ 889,340
Balance, Shares at Jun. 30, 2024   161,802,000